Neuroepidemiology

Original Paper

Epidemiology of Stroke in the Netherlands from 1972 to 1994: The End of the Decline in Stroke Mortality

Reitsma J.B.a,c · Limburg M.b,c · Kleijnen J.a · Bonsel G.J.a · Tijssen J.G.P.a

Author affiliations

Departments of a Clinical Epidemiology and Biostatistics and b Neurology, Academic Medical Center, University of Amsterdam, and c Netherlands Heart Foundation, The Hague, The Netherlands

Related Articles for ""

Neuroepidemiology 1998;17:121–131

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Published online: June 12, 1998
Issue release date: May – June

Number of Print Pages: 11
Number of Figures: 6
Number of Tables: 2

ISSN: 0251-5350 (Print)
eISSN: 1423-0208 (Online)

For additional information: https://www.karger.com/NED

Abstract

In 1994, stroke was responsible for the death of 4,994 men and 7,601 women in the Netherlands, corresponding to 7.5% of all deaths in men and 11.4% in women. Age-adjusted stroke mortality declined by 39% for men and by 45% for women between 1972 and 1994. However, the decline in mortality levelled off after 1987. In contrast to mortality, age-adjusted discharge rates increased by 47% for men and by 28% for women during the study period. The decline in mortality was equally distributed over the age groups, while the increase in the number of hospital admissions was more pronounced in the older age groups. The analyses by diagnostic subgroups of stroke showed the importance of increasing diagnostic capabilities in the hospital setting. The use of diagnostic subgroups in national mortality data was of limited value, illustrated by the fact that 70% of all stroke deaths in 1994 belonged to the ill-defined type of stroke.




Related Articles:


References

  1. Bonita R, Stewart A, Beaglehole R: International trends in stroke mortality: 1970–1985. Stroke 1990;21:989–992.
  2. Bonita R: Epidemiology of stroke. Lancet 1992;339:342–344.
  3. Herman B, Leyten ACM, van Luijk JH, Frenken CWGM, Op de Coul AAW, Schulte BPM: Epidemiology of stroke in Tilburg, the Netherlands: The population-based stroke incidence register. 2. Incidence, initial clinical picture and medical care, and three-week case fatality. Stroke 1982;13:629–634.
    External Resources
  4. Evers SMAA, Engel GL, Ament AJHA: Cost of stroke in the Netherlands from a societal perspective. Stroke 1997;28:1375–1381.
  5. Bergman L, van der Meulen JHP, Limburg M, Habbema JDF: Costs of medical care after first-ever stroke in the Netherlands. Stroke 1995;26:1830–1836.
  6. Thom TJ, Epstein FH: Heart disease, cancer, and stroke mortality trends and their interrelations: An international perspective. Circulation 1994;90:574–582.
  7. Lanska DJ, Peterson PM: Geographic variation in the decline of stroke mortality in the United States. Stroke 1995;26:1159–1165.
  8. Cooper R, Sempos C, Hsieh SC, Kovar MG: Slowdown in the decline of stroke mortality in the United States, 1978–1986. Stroke 1990;21:1274–1279.
  9. Broderick JP, Phillips SJ, Whisnant JP, O’Fallon WM, Bergstralh EJ: Incidence rates of stroke in the eighties: The end of the decline in stroke? Stroke 1989;20:577–582.
  10. Harmsen P, Tsipogianni A, Wilhelmsen L: Stroke incidence rates were unchanged, while fatality rates declined, during 1971–1987 in Göteborg, Sweden. Stroke 1992;23:1410–1415.
  11. Bonita R, Broad JB, Beaglehole R: Changes in stroke incidence and case-fatality in Auckland, New Zealand, 1981–91. Lancet 1993;342:1470–1473.
  12. Sarti C, Tuomilehto J, Sivenius J, Kaarsalo E, Narva EV, Salmi K, Salomaa V, Torppa J: Stroke mortality and case-fatality rates in three geographic areas of Finland from 1983 to 1986. Stroke 1993;24:1140–1147.
  13. McGovern PG, Burke GL, Sprafka JM, Xue S, Folsom AR, Blackburn H: Trends in mortality, morbidity, and risk factor levels for stroke from 1960 through 1990. The Minnesota Heart Survey. JAMA 1992;268:753–759.
  14. Jorgensen HS, Plesner AM, Hübbe P, Larsen K: Marked increase of stroke incidence in men between 1972 and 1990 in Frederiksberg, Denmark. Stroke 1992;23:1701–1704.
  15. Statistics Netherlands: Deaths by Causes of Death, Age and Gender. Voorburg, Central Bureau of Statistics, Annual Reports.
  16. World Health Organization: World Health Statistics Annual. Geneva, WHO, 1995.
  17. Breslow NE, Day NE: Fitting models to grouped data; in Heseltine E (ed): Statistical Methods in Cancer Research. New York, Oxford University Press, 1987, vol II: The Design and Analysis of Cohort Studies.
  18. Thorvaldsen P, Kuulasmaa K, Rajakangas A, Rastenyte D, Sarti C, Wilhelmsen L: Stroke trends in the WHO MONICA Project. Stroke 1997;28:500–506.
  19. Ruwaard D, Kramers PGN, van den Bergh Jeths A, Achterberg PW (eds): Public Health Status of the Dutch Population over the Period 1950–2010. The Hague, Sdu Uitgeverij Plantijnstraat, 1994.
  20. Vartiainen E, Sarti C, Tuomilehto J, Kuulasmaa K: Do changes in cardiovascular risk factors explain changes in mortality from stroke in Finland? BMJ 1995;310:901–904.
  21. van den Hoogen HJM, Huygen FJA, Schellekens JWG, Straat JM, van der Velden HGM: Morbidity Figures from General Practices (1978–1982) (in Dutch). Nijmegen, University Department of General Practice, 1985.
  22. van der Velden J, de Bakker DH, Claessens AAMC, Schellevis FG: Dutch National Survey of General Practices, Morbidity in General Practices (in Dutch). Utrecht, Nederlands Instituut voor Onderzoek van de Eerstelijns Gezondheidszorg (NIVEL), 1991.
  23. McGovern PG, Pankow JS, Burke GL, Shahar E, Sprafka JM, Folsom AR, Blackburn H: Trends in survival of hospitalized stroke patients between 1970 and 1985: The Minnesota Heart Survey. Stroke 1993;24:1640–1648.
  24. Shahar E, McGovern PG, Sprafka JM, Pankow JS, Doliszny KM, Luepker RV, Blackburn H: Improved survival of stroke patients during the 1980s: The Minnesota Stroke Survey. Stroke 1995;26:1–6.
  25. Langhorne P, Williams BO, Gilchrist W, Howie K: Do stroke units save lives? Lancet 1993;342:395–398.
  26. Brown RD Jr, Whisnant JP, Sicks JD, O’Fallon WM, Wiebers DO: Stroke incidence, prevalence, and survival: Secular trends in Rochester, Minnesota, through 1989. Stroke 1996;27:373–380.
  27. Whisnant JP, O’Fallon WM, Sicks J, Ingall T: Stroke incidence with hypertension and ischaemic heart disease in Rochester, Minnesota. Ann Epidemiol 1993;3:480–482.
  28. Bonneux L, Looman CWN, Barendregt JJ, van der Maas PJ: Regression analysis of recent changes in cardiovascular morbidity and mortality in the Netherlands. BMJ 1997;314:789–792.
  29. Sandercock P, Molyneux A, Warlow C: Value of computed tomography in patients with stroke: Oxfordshire Community Stroke Project. BMJ 1985;290:193–197.
  30. Engel LW, Strauchen JA, Chiazze L Jr, Heid M: Accuracy of death certification in an autopsied population with specific attention to malignant neoplasms and vascular diseases. Am J Epidemiol 1980;111:99–112.
    External Resources
  31. Corwin LI, Wolf PA, Kannel WB, McNamara PM: Accuracy of death certification of stroke: The Framingham Study. Stroke 1982;13:818–821.
  32. Asplund K, Bonita R, Kuulasmaa K, Rajakangas AM, Feigin V, Schaedlich H, Suzuki K, Thorvaldsen P, Tuomilehto J: Multinational comparisons of stroke epidemiology: Evaluation of case ascertainment in the WHO MONICA Stroke Study. Stroke 1995;26:355–360.
  33. Bamford J, Sandercock P, Warlow C, Gray M: Why are patients with acute stroke admitted to hospital? BMJ 1986;292:1369–1372.
  34. Limburg M, van der Meer K, Schadé E, van Crevel H: Should stroke patients be admitted to hospital? (in Dutch): Ned Tijdschr Geneeskd 1992;136:415–420.
  35. Schuling J, Greidanus J: Stroke patients in the acute phase: Characteristics and management. Ned Tijdschr Geneeskd 1992;136:420–425.
  36. van Ree JW, Arts H, van den Hoogen H: CVA and TIA in general practice: Data of incidence and referrals (in Dutch). Tijdschr Gerontol Geriatr 1987;18:55–60.
    External Resources
  37. van der Meer K, Smith RJA: CVA patients in general practice: A study among 1 percent of the Dutch population (in Dutch). Huisarts Wet 1990;33:141–144.
  38. Bots ML, Looman SJ, Koudstaal PJ, Hofman A, Hoes AW, Grobbee DE: Prevalence of stroke in the general population: The Rotterdam Study. Stroke 1996;27:1499–1501.
  39. Bonita R, Broad JB, Anderson NE, Beaglehole R: Approaches to the problems of measuring the incidence of stroke: The Auckland Stroke Study, 1991–1992. Int J Epidemiol 1995;24:535–542.
  40. Thorvaldsen P, Asplund K, Kuulasmaa K, Rajakangas AM, Schroll M: Stroke incidence, case fatality, and mortality in the WHO MONICA project. Stroke 1995;26:361–367.
  41. Leibson CL, Naessens JM, Brown RD, Whisnant JP: Accuracy of hospital discharge abstracts for identifying stroke. Stroke 1994;25:2348–2355.
  42. Stegmayr B, Asplund K: Measuring stroke in the population: Quality of routine statistics in comparison with a population-based stroke registry. Neuroepidemiology 1992;11:204–213.
  43. May DS, Kittner SJ: Use of medicare claims data to estimate national trends in stroke incidence, 1985–1991. Stroke 1994;25:2343–2347.
  44. Modan B, Wagener DK: Some epidemiological aspects of stroke: Mortality/morbidity trends, age, sex, race, socioeconomic status. Stroke 1992;23:1230–1236.
  45. Baum HM, Goldstein M: Cerebrovascular disease type specific mortality: 1968–1977. Stroke 1982;13:810–817.
    External Resources
  46. Weir CJ, Murray GD, Adams FG, Muir KW, Grosset DG, Lees KR: Poor accuracy of stroke scoring systems for differential clinical diagnosis of intracranial haemorrhage and infarction. Lancet 1994;344:999–1002.
  47. Besson G, Robert C, Hommel M, Perret J: Is it clinically possible to distinguish nonhemorrhagic infarct from hemorrhagic stroke? Stroke 1995;26:1205–1209.
  48. van der Meulen JHP, Limburg M, van Straten A, Habbema JDF: Computed tomographic brain scans and antiplatelet therapy after stroke: A study of the quality of care in Dutch hospitals. Stroke 1996;27:633–638.
  49. Niessen LW, Barendregt JJ, Bonneux L, Koudstaal PJ: Stroke trends in an aging population. Stroke 1993;24:931–939.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Published online: June 12, 1998
Issue release date: May – June

Number of Print Pages: 11
Number of Figures: 6
Number of Tables: 2

ISSN: 0251-5350 (Print)
eISSN: 1423-0208 (Online)

For additional information: https://www.karger.com/NED


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP